REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Eagle Indo Pharma (Indonesia)

Main Activities: Medicinal and Botanical Manufacturing
Full name: PT Eagle Indo Pharma Profile Updated: February 28, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

PT Eagle Indo Pharma is an enterprise in Indonesia, with the main office in Tangerang. It operates in the Medicinal and Botanical Manufacturing sector. PT Eagle Indo Pharma was incorporated on May 26, 1973. There are currently 5,001 - 10,000 (2024) people employed by PT Eagle Indo Pharma. From the latest financial highlights, PT Eagle Indo Pharma reported a net sales revenue increase of 5.19% in 2023. A growth of 3.96% was recorded in its total assets.

Headquarters
RT 001 RW 004
Tangerang; Banten; Postal Code: 15133

Contact Details: Purchase the PT Eagle Indo Pharma report to view the information.

Website: http://www.caplang.com

Basic Information
Total Employees:
Purchase the PT Eagle Indo Pharma report to view the information.
Outstanding Shares:
Purchase the PT Eagle Indo Pharma report to view the information.
Registered Capital:
Purchase the PT Eagle Indo Pharma report to view the information.
Incorporation Date:
May 26, 1973
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Eagle Indo Pharma report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
5.19%
Total operating revenue
5.19%
Total assets
3.96%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?